DBV Technologies | Cassa E Equivalenti



Cash And Equivalent Cambiamento Data
Acadia Pharmaceuticals USD 755.99M 190.66M 2024-12
Alnylam Pharmaceuticals USD 1.02B 53.23M 2025-03
Amarin USD 156.94M 58.98M 2024-09
BioMarin Pharmaceutical USD 612.03M 1.19M 2025-03
DBV Technologies USD 32.5M 4.51M 2024-12
Halozyme Therapeutics USD 115.85M 38.47M 2024-12
Incyte USD 2.41B 720.83M 2025-03
Insmed USD 555.03M 93.58M 2024-12
Ionis Pharmaceuticals USD 264.19M 22.12M 2025-03
Neurocrine Biosciences USD 233M 116.1M 2024-12
PTC Therapeutics USD 779.71M 253.71M 2024-12
Sarepta Therapeutics USD 1.1B 905.16M 2024-12
Ultragenyx Pharmaceutical USD 173.73M 23.11M 2024-12
United Therapeutics USD 1.9B 202.7M 2025-03



DBV Technologies Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.